Study suggests PD-1 inhibitors against aggressive pediatric brain cancer subtype
- OPACC
- Jan 29, 2018
- 1 min read
A University of Colorado Cancer Center study published in the journal Pediatric Blood Cancers lays the scientific groundwork for the use of PD-1 inhibitors with an aggressive form of brain cancer, namely supratentorial pediatric ependymoma.
コメント